Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder

PLoS One. 2017 Mar 23;12(3):e0172692. doi: 10.1371/journal.pone.0172692. eCollection 2017.

Abstract

Background: Subsyndromal symptomatic depression (SSD) is a subtype of subthreshold depressive and can lead to significant psychosocial functional impairment. Although the pathogenesis of major depressive disorder (MDD) and SSD still remains poorly understood, a set of studies have found that many same genetic factors play important roles in the etiology of these two disorders. Nowadays, the differential gene expression between MDD and SSD is still unknown. In our previous study, we compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD and matched healthy controls (8 subjects in each group), and finally determined 48 gene expression signatures. Based on these findings, we further clarify whether these genes mRNA was different expressed in peripheral blood in patients with SSD, MDD and healthy controls (60 subjects respectively).

Method: With the help of the quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR), we gained gene relative expression levels among the three groups.

Results: We found that there are three of the forty eight co-regulated genes had differential expression in peripheral blood among the three groups, which are CD84, STRN, CTNS gene (F = 3.528, p = 0.034; F = 3.382, p = 0.039; F = 3.801, p = 0.026, respectively) while there were no significant differences for other genes.

Conclusion: CD84, STRN, CTNS gene may have significant value for performing diagnostic functions and classifying SSD, MDD and healthy controls.

MeSH terms

  • Adult
  • Case-Control Studies
  • Depression / genetics*
  • Depressive Disorder, Major / genetics*
  • Female
  • Gene Expression / genetics*
  • Humans
  • Leukocytes / metabolism
  • Male
  • RNA, Complementary / genetics
  • RNA, Messenger / genetics
  • Severity of Illness Index

Substances

  • RNA, Complementary
  • RNA, Messenger

Grants and funding

This work was supported by the National Natural Science Foundation of China (91232719, 81171272), the National High-tech R&D Program (863 Program, 2006AA02Z430); partially supported by The “12th Five-year Plan” of National Key Technologies R&D Program (2012BAI01B04), the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH, 2011-873), Shanghai Public Health Training Scheme outstanding academic leaders (GWDTR201227); The National Natural Science Foundation of China (Grant# 81301159), Training Plan for Excellent Academic Leaders of Shanghai Health System (Grant# XBR2013087) and Shanghai Key Medicine Specialties Program (Grant# ZK2012A12). The funder had no role in the design, collection, management, analysis, and approval of manuscript or decision to submit the manuscript for publication.